School of Stomatology and Medicine, Foshan University, Foshan, 528000, Guangdong Province, China.
Key Laboratory of RNA Biology & National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
Sci Rep. 2017 Jul 25;7(1):6471. doi: 10.1038/s41598-017-01705-4.
MarR family proteins are transcriptional regulators that control expression of bacterial proteins involved in metabolism, virulence, stress responses and multi-drug resistance, mainly via ligand-mediated attenuation of DNA binding. Greater understanding of their underlying regulatory mechanism may open up new avenues for the effective treatment of bacterial infections. To gain molecular insight into the mechanism of Rv2887, a MarR family protein in M. tuberculosis, we first showed that it binds salicylate (SA) and para-aminosalicylic acid (PAS), its structural analogue and an antitubercular drug, in a 1:1 stoichiometry with high affinity. Subsequent determination and analysis of Rv2887 crystal structures in apo form, and in complex with SA, PAS and DNA showed that SA and PAS bind to Rv2887 at similar sites, and that Rv2887 interacts with DNA mainly by insertion of helix α4 into the major groove. Ligand binding triggers rotation of the wHTH domain of Rv2887 toward the dimerization domain, causing changes in protein conformation such that it can no longer bind to a 27 bp recognition sequence in the upstream region of gene Rv0560c. The structures provided here lay a foundation for the design of small molecules that target Rv2887, a potential new approach for the development of anti-mycobacterials.
MarR 家族蛋白是转录调控因子,可控制参与代谢、毒力、应激反应和多药耐药性的细菌蛋白的表达,主要通过配体介导的 DNA 结合减弱来实现。深入了解它们的潜在调控机制可能为有效治疗细菌感染开辟新途径。为了深入了解结核分枝杆菌 MarR 家族蛋白 Rv2887 的作用机制,我们首先表明它以 1:1 的化学计量比与高亲和力结合水杨酸(SA)和对氨基水杨酸(PAS),这是它的结构类似物和一种抗结核药物。随后确定和分析了 Rv2887 的apo 形式、与 SA、PAS 和 DNA 形成的复合物的晶体结构,表明 SA 和 PAS 结合到 Rv2887 上的相似部位,并且 Rv2887 主要通过将螺旋 α4 插入主沟与 DNA 相互作用。配体结合触发 Rv2887 的 wHTH 结构域向二聚化结构域旋转,导致蛋白质构象发生变化,使其无法再与基因 Rv0560c 上游区域的 27bp 识别序列结合。此处提供的结构为设计靶向 Rv2887 的小分子奠定了基础,这是开发抗分枝杆菌药物的一种新方法。